Retatrutide, a novel dual agonist of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor , is exhibiting promising outcomes in preliminary human assessments . Current research https://atozbookmark.com/story21223404/retatrutide-emerging-investigations-and-potential-therapeutic-roles